Article Text

Download PDFPDF

Captopril in hypertension after renal transplantation.
  1. M. K. Chan,
  2. P. Sweny,
  3. A. M. El Nahas,
  4. K. Farrington,
  5. O. N. Fernando,
  6. J. F. Moorhead


    Eight hypertensive renal allograft recipients who had received captopril are presented. Captopril in a maximal daily dose of 250 mg enabled the withdrawal of large doses of beta-blocking agents and vasodilators. Blood pressure was satisfactorily controlled in all except one. No adverse side effects were observed other than the 'first dose' effect which resulted in transient anuria in one patient. Captopril appears to be a useful agent in the management of severe hypertension after renal transplantation.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.